Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
O’Brien DP. et al, (2025), Journal of Proteome Research, 24, 479 - 490
MITOCHONDRIAL DYSFUNCTION IN NEUROSCIENCE: RECENT DEVELOPMENTS IN USP30 INHIBITORS
Worm K. et al, (2024), Medicinal Chemistry Reviews, 37 - 58
Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides
O'Brien DP. et al, (2023), Molecular & Cellular Proteomics, 22, 100609 - 100609
USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation
Rusilowicz-Jones EV. et al, (2020), Life Science Alliance, 3, e202000768 - e202000768
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays
Le Bihan Y-V. et al, (2019), European Journal of Medicinal Chemistry, 177, 316 - 337
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Tumber A. et al, (2017), Cell Chemical Biology, 24, 371 - 380
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin
Jones P. et al, (2017), Journal of Medicinal Chemistry, 60, 767 - 786
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors
Bavetsias V. et al, (2016), Journal of Medicinal Chemistry, 59, 1388 - 1409
Recent Progress in Histone Demethylase Inhibitors
McAllister TE. et al, (2016), Journal of Medicinal Chemistry, 59, 1308 - 1329
Targeting histone lysine demethylases — Progress, challenges, and the future
Thinnes CC. et al, (2014), Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1839, 1416 - 1432
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor
England KS. et al, (2014), MedChemComm, 5, 1879 - 1886
Acidic triazoles as soluble guanylate cyclase stimulators
Roberts LR. et al, (2011), Bioorganic & Medicinal Chemistry Letters, 21, 6515 - 6518
An improved synthesis of a novel α1A partial agonist including a new two-step synthesis of 4-fluoropyrazole
England K. et al, (2010), Tetrahedron Letters, 51, 2849 - 2851